Picture of Twist Bioscience logo

TWST Twist Bioscience Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Twist Bioscience, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue54.490.1132204245
Cost of Revenue
Gross Profit6.9628.751.784.289.7
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses163230285434462
Operating Profit-109-140-153-230-217
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-107-140-154-228-203
Provision for Income Taxes
Net Income After Taxes-108-140-152-218-205
Net Income Before Extraordinary Items
Net Income-108-140-152-218-205
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-108-140-152-218-205
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-3.92-3.2-3.15-4.1-3.41